Clinical Trials A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye Disease by ClinicalTrialsFeed • 2016/09/12 • 0 Comments Status: Active, not recruiting, Condition Summary: Keratoconjunctivitis Sicca Full Story →